van der Reijden BA - Search Results

1

Effectiveness of digital care platform CMyLife for patients with chronic myeloid leukemia: results of a patient-preference trial.

Verweij L, Ector GICG, Smit Y, van Vlijmen B, van der Reijden BA, Hermens RPMG, Blijlevens NMA. Verweij L, et al. Among authors: van der reijden ba. BMC Health Serv Res. 2023 Mar 8;23(1):228. doi: 10.1186/s12913-023-09153-9. BMC Health Serv Res. 2023. PMID: 36890512 Free PMC article. Clinical Trial.

2

Sequence polymorphism systems for quantitative real-time polymerase chain reaction to characterize hematopoietic chimerism-high informativity and sensitivity as well as excellent reproducibility and precision of measurement.

Willasch A, Schneider G, Reincke BS, Shayegi N, Kreyenberg H, Kuci S, Weber G, Van Der Reijden B, Niethammer D, Klingebiel T, Bader P. Willasch A, et al. Lab Hematol. 2007;13(3):73-84. doi: 10.1532/LH96.07004. Lab Hematol. 2007. PMID: 17984038

3

Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676).

de Vetten MP, Jansen JH, van der Reijden BA, Berger MS, Zijlmans JM, Löwenberg B. de Vetten MP, et al. Among authors: van der reijden ba. Br J Haematol. 2000 Oct;111(1):277-9. doi: 10.1046/j.1365-2141.2000.02402.x. Br J Haematol. 2000. PMID: 11091212 Free article.

4

Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis.

Van der Reijden BA, de Wit L, van der Poel S, Luiten EB, Lafage-Pochitaloff M, Dastugue N, Gabert J, Löwenberg B, Jansen JH. Van der Reijden BA, et al. Among authors: van der poel s. Hematol J. 2001;2(3):206-9. doi: 10.1038/sj.thj.6200103. Hematol J. 2001. PMID: 11920247

5

Deletion of the multidrug resistance-associated protein (MRP1) gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impact.

Döhner K, Schlenk RF, van der Reijden BA, Döhner H. Döhner K, et al. Among authors: van der reijden ba. Leukemia. 2000 Jun;14(6):1154. doi: 10.1038/sj.leu.2401804. Leukemia. 2000. PMID: 10865983 No abstract available.

6

A gene for a myosin peptide is disrupted by the inv(16)(p13q22) in acute nonlymphocytic leukemia M4Eo.

van der Reijden BA, Dauwerse JG, Wessels JW, Beverstock GC, Hagemeijer A, van Ommen GJ, Breuning MH. van der Reijden BA, et al. Among authors: van ommen gj. Blood. 1993 Nov 15;82(10):2948-52. Blood. 1993. PMID: 8219185 Free article.

7

Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusion.

van der Reijden BA, Simons A, Luiten E, van der Poel SC, Hogenbirk PE, Tönnissen E, Valk PJ, Löwenberg B, De Greef GE, Breuning MH, Jansen JH. van der Reijden BA, et al. Among authors: van der poel sc. Br J Haematol. 2002 Aug;118(2):411-8. doi: 10.1046/j.1365-2141.2002.03738.x. Br J Haematol. 2002. PMID: 12139724 Free article.

8

Rapid simultaneous screening of factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole blood.

Gomez E, van der Poel SC, Jansen JH, van der Reijden BA, Lowenberg B. Gomez E, et al. Among authors: van der reijden ba, van der poel sc. Blood. 1998 Mar 15;91(6):2208-9. Blood. 1998. PMID: 9490710 Free article. No abstract available.

9

Rapid identification of CBFB-MYH11-positive acute myeloid leukemia (AML) cases by one single MYH11 real-time RT-PCR.

van der Reijden BA, Massop M, Tönnissen E, van de Locht L, Muus P, de Witte T, Jansen JH. van der Reijden BA, et al. Among authors: van de locht l. Blood. 2003 Jun 15;101(12):5085-6. doi: 10.1182/blood-2003-02-0405. Blood. 2003. PMID: 12788791 Free article. No abstract available.

10

Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered.

van der Reijden BA, Dauwerse HG, Giles RH, Jagmohan-Changur S, Wijmenga C, Liu PP, Smit B, Wessels HW, Beverstock GC, Jotterand-Bellomo M, Martinet D, Mühlematter D, Lafage-Pochitaloff M, Gabert J, Reiffers J, Bilhou-Nabera C, van Ommen GJ, Hagemeijer A, Breuning MH. van der Reijden BA, et al. Among authors: van ommen gj. Oncogene. 1999 Jan 14;18(2):543-50. doi: 10.1038/sj.onc.1202321. Oncogene. 1999. PMID: 9927211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page